Arena Pharmaceuticals Inc
ARNA
ARNA was delisted on the 10th of March, 2022.
129 hedge funds and large institutions have $401M invested in Arena Pharmaceuticals Inc in 2014 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 42 increasing their positions, 37 reducing their positions, and 14 closing their positions.
71% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 14
14% more repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 37
7% more funds holding
Funds holding: 121 → 129 (+8)
11% less capital invested
Capital invested by funds: $451M → $401M (-$50.3M)
46% less call options, than puts
Call options by funds: $10.8M | Put options by funds: $19.8M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$6.56M |
| 2 |
NI
Numeric Investors
Boston,
Massachusetts
|
+$5.39M |
| 3 |
DM
Deerfield Management
New York
|
+$4.49M |
| 4 |
D.E. Shaw & Co
New York
|
+$3.98M |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$3.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GC
Guggenheim Capital
Chicago,
Illinois
|
-$3.02M |
| 2 |
Renaissance Technologies
New York
|
-$2.2M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$2.14M |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$2.1M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$2.03M |
ARNA Hedge Fund Activity: Q4 2014 in Review
129 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q4 2014, worth a combined $401M — down 11% from $451M a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new ARNA positions and 14 closed out — a net gain of 10 holders — while 42 added to existing stakes and 37 trimmed.
The largest buyer was Millennium Management, adding an estimated $6.56M. The largest seller was Guggenheim Capital, cutting an estimated $3.02M.
- 129 institutional investors held Arena Pharmaceuticals Inc (ARNA) as of Q4 2014, up from 121 in Q3 2014.
- Funds reported $401M of Arena Pharmaceuticals Inc stock for Q4 2014, down 11% quarter-over-quarter.
- 24 funds opened new Arena Pharmaceuticals Inc positions in Q4 2014 and 14 closed out, a net change of +10 holders.
- The largest Arena Pharmaceuticals Inc buyer in Q4 2014 was Millennium Management, an estimated $6.56M added.
- The largest Arena Pharmaceuticals Inc seller in Q4 2014 was Guggenheim Capital, an estimated $3.02M sold.
Based on aggregated 13F filings for Q4 2014.